Liminatus Pharma, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Liminatus Pharma, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($1.82M) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2025 | $113.3K | Oct 6, 2025 |
| Q3 | 2025 | Jun 30, 2025 | $113.3K | Nov 14, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($327.5K) | Nov 14, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($255) | Jun 2, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($327.5K) | Oct 6, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($601.4K) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($961.2K) | Oct 6, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($961.2K) | Nov 14, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($1.75M) | Oct 6, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($1.75M) | Nov 14, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($247) | Jun 2, 2025 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($701.2K) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($1.12M) | Oct 6, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($255) | Jun 2, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($543.1K) | Nov 14, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($909.2K) | Oct 6, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($247) | Jun 2, 2025 |